Objectives-To investigate the correlation among ultrasound-guided diffuse optical tomography (DOT), microvessel density, and breast cancer prognosis.
B
reast cancer has become the most common type of malignant tumor in Chinese women. 1 With comprehensive treatments such as surgery, radiotherapy, chemotherapy, and immunotherapy, the disease-free survival of patients with breast cancer has been greatly prolonged; however, even at stage I, 5.4% of all patients still have recurrence or metastasis within 5 years after surgery. 2 Therefore, it is important to conduct in-depth stratification studies of the clinical and imaging features of patients with breast cancer and to screen patients with a high risk of metastasis before surgery.
Currently, the methods used for breast examination before surgery include ultrasound (US) imaging, radiography, and magnetic resonance imaging (MRI). These imaging modalities can evaluate breast cancer in terms of morphologic characteristics or tumor blood supply. In addition, optical imaging has been successfully applied to breast imaging. Ultrasound-guided diffuse optical tomography (DOT) uses near-infrared light to evaluate the absorption and scattering properties of biological tissues under US localization. It is a noninvasive imaging modality. Before surgery, using DOT to evaluate a tumor's blood supply can provide more information for physicians, which is valuable for the treatment and prognosis of patients with breast cancer. Currently, DOT is mainly applied to the diagnosis of benign and malignant breast diseases 3, 4 and to the therapeutic evaluation of neoadjuvant chemotherapy for breast cancer. 5, 6 It can measure the total hemoglobin (Hb) concentration, which reflects the tumor's blood supply, which in turn is substantially associated with the prognosis of the tumor. 7, 8 By inference, DOT may be associated with the prognosis of breast cancer. However, few researchers have focused on the relationship between DOT and the prognosis.
In our study, we performed DOT examinations in patients with breast cancer before surgery, counted the microvessel density of the lesions after surgery, and analyzed the correlation between total Hb and microvessel density. These results were used to verify the relationship between the total Hb and tumor blood supply. Then we conducted an extensive follow-up of patients with breast cancer and analyzed the differences in the total Hb concentration and microvessel density among breast cancers with different prognoses to determine the relationship between DOT and the prognosis and to preliminarily test the value of DOT in predicting the prognosis of breast cancer.
Materials and Methods

Patients
This study was approved by the Institutional Review Board of Peking Union Medical College Hospital, and all patients signed informed consent forms. From October 2007 to February 2010, 184 female patients with breast cancer with only a single lesion underwent a preoperative conventional breast US examination and USguided DOT at Peking Union Medical College Hospital, and all of their diagnoses were pathologically confirmed. All 184 cases were included in the study. All patients' pTNM stages were determined according to the AJCC Cancer Staging Manual, seventh edition (American Joint Committee on Cancer, Chicago, IL). Follow-up began on the first day after surgery. Follow-up of patients with recurrence or metastatic disease ended at the time when recurrence or metastatic disease was confirmed for the first time. Patients without recurrence or metastatic disease were followed until August 2013. During follow-up, there were only 23 patients with recurrence or metastatic disease after surgery. Among them, recurrence occurred in 1 patient, and metastatic disease occurred in 22 patients. They all had invasive ductal carcinomas.
First, we conducted a paired study. Among these 23 patients, 18 were included in the metastasis group. The inclusion criteria were as follows: (1) diagnosis of invasive ductal carcinoma; (2) no distant metastases before surgery; (3) recurrence or metastatic disease identified by imaging or biopsy at least 3 months after surgery; (4) recurrence or metastatic disease occurred within 3 years after surgery; and (5) availability of a matching control patient.
The factors by which cases and controls were matched included the pathologic cancer type, pTNM classification, age, follow-up duration, and treatment methods. The corresponding patients in the metastasis and control groups were required to have the same pathologic type, the same pTNM classification, and a similar age (age difference of 5 years). In the metastasis group, recurrence or metastatic disease occurred within 3 years after surgery, and the control group did not have recurrence or metastatic disease within 3 years after surgery. Treatment methods in the control group were less extensive or equal to those in the metastasis group.
A total of 18 patients without recurrence or metastatic disease were included in the control group and were matched 1:1 with the metastasis group. The inclusion criteria were as follows: (1) diagnosis of invasive ductal carcinoma; (2) the same pTNM classification as the corresponding patient in the metastasis group; (3) an age difference of 5 years or less compared with the matched patient; (4) no recurrence or metastasis within 3 years after surgery; and (5) the use of a less-extensive or equal treatment method compared with the corresponding patient in the metastasis group. The previously described 36 patients were included in the paired study and correlation analysis between total Hb and microvessel density.
Next, we conducted a diagnostic test of DOT by conducting a receiver operating characteristic (ROC) curve analysis. All 184 cases, including 23 metastatic cases and 161 nonmetastatic cases, were included in the evaluation of DOT as a diagnostic test.
Instruments
All patients' conventional breast US examinations were performed with a high-frequency transducer (L12-5, iU22; Philips Healthcare, Bothell, WA; or 12L, LOGIQ 7; GE Healthcare, Madison, WI). Ultrasound-guided DOT was performed with an OPTIMUS Type II breast diagnostic system (XinaoMDT Technology Co, Ltd, Langfang, China), which is a dual-mode imaging system composed of a diagnostic US device (Terason T3000 US system with a linear 7-12-MHz transducer; Teratech, Burlington, MA) and a DOT system. The linear US transducer is located in the center of the compound probe, which is used to locate the tumor. Nine optical fibers and 10 optical detectors lie along the two sides of the US transducer. Optical fibers emit two different wavelengths of near-infrared light (785 and 830 nm) to scan the tumor tissues, and optical detectors receive the returned wave. According to the data difference in the corresponding sites of bilateral breast tissue, the tissue absorption intensity at different depths can be evaluated. Because deoxygenated Hb and oxygenated Hb are the main absorbers of near-infrared light, the tissue absorption intensity reflects the content of deoxygenated and oxygenated Hb in the tissues. The total Hb is the sum of the two. Different absorption intensities are color coded on the DOT map, with red indicating increased photon absorption and a higher total Hb concentration and blue indicating decreased photon absorption and a lower total Hb concentration. 9 Study Design A routine US examination was performed before surgery, and the US characteristics of all lesions were recorded. Ultrasound-guided DOT was then conducted to measure the total Hb concentrations in all lesions and to generate reconstructed optical absorption maps. After surgery, the medical histories of all patients were reviewed; the patients were followed by telephone; and their clinical characteristics, treatment methods used, and reexamination results were recorded.
After surgery, we retrospectively reviewed all pathologic sections from the metastasis and control groups and conducted immunohistochemical staining. CD34 was used as a marker of vascular endothelial cells. The microvessel densities of the groups were also determined. We analyzed the correlation between total Hb and microvessel density. The total Hb concentrations and microvessel densities of the metastasis and control groups were then statistically analyzed. Next, an ROC analysis was used to evaluate the diagnostic performance of DOT in predicting recurrence or metastasis. All DOT measurements were performed by 2 experienced physicians who had performed US diagnosis for more than 5 years, and all microvessel densities were counted by 2 experienced pathologists who had performed pathologic diagnosis for more than 5 years.
Immunohistochemical Staining for CD34
All surgical specimens were fixed with a 10% formaldehyde solution and embedded in paraffin, and 4-lm serial sections were created and used to determine CD34 expression. All sections were dewaxed, rehydrated, and washed twice in phosphate-buffered saline for 5 minutes. After incubation in 0.3% hydrogen peroxide for 30 minutes and 2 washes in phosphate-buffered saline for 5 minutes, a high-pressure retrieval method was used. The sections were then incubated with a mouse antihuman monoclonal anti-CD34 antibody (Code M7165, 1:50 dilution; DAKO, Glostrup, Denmark) at 4 8C overnight. Next, the sections were returned to room temperature and washed twice in phosphate-buffered saline for 5 minutes. Finally, they were incubated with a goat antimouse secondary antibody to identify the primary antibody and thus detect CD34.
Microvessel Counting Method
First, a digital section-scanning device (NanoZoomer 2.0; Hamamatsu Photonics Co, Hamamatsu, Japan) was used to scan the stained sections and create highresolution digital images. Next, the images were evaluated on a computer at a resolution of 1366 3 768. The microvessel counting method reported by Weidner et al 10 was then used. The 5 regions with the highest microvascular densities at 350 magnification were chosen as hot spots, and an area of 0.2 mm 2 within the whole-screen image at 3 200 magnification (equivalent to a field at 3400 magnification) was captured and used to determine the microvessel density. Any brownstaining endothelial cells or endothelial cell clusters that could be distinguished from adjacent microvessels, tumor cells, and other connective tissue were considered a single vessel. The vascular lumen was not considered an essential structure of the microvasculature, and red blood cells were not used to define the vascular lumen. Branching structures were considered single vessels.
Statistical Analysis
Data analysis was performed with the SPSS version 17.0 software package for Windows (IBM Corporation, Armonk, NY). The total Hb concentration and microvessel density are presented as means 6 standard deviations. A paired-samples t test was used to compare the total Hb concentrations and microvessel densities of the metastasis and control groups. Linear regression and scatterplots were used to analyze the correlation between microvessel density and total Hb. An ROC curve analysis was used to evaluate the diagnostic performance of DOT. P < .05 indicated a statistically significant difference.
Results
In the metastasis group, the mean age was 51.7 6 10.5 (range, 34-70) years, and the mean maximum lesion diameter was 2.7 6 1.1 (range, 0.8-4.5) cm. Among these patients, 9 were at stage III; 7 were at stage II; and 2 were at stage I. The mean duration of follow-up was 17.8 6 10.9 (range, 4-36) months. The locations of recurrence or metastasis in confirmed cases were as follows: bone (6), liver (3), lungs (2), chest wall (1), axillary lymph nodes (1), supraclavicular lymph nodes (1), and multiple organs (4). After surgery, 13 patients were treated with modified radical mastectomy and chemotherapy; 3 were treated with modified radical mastectomy, chemotherapy, and radiotherapy; 1 was treated with modified radical mastectomy, chemotherapy, radiotherapy, and hormonotherapy; and 1 was treated with modified radical mastectomy, chemotherapy, and targeted therapy.
In the control group, the mean age was 52.1 6 11.7 (range, 30-70) years, and the mean maximum lesion diameter was 2.5 6 1.0 (range, 1.0-4.2) cm. Among these patients, 9 were at stage III; 7 were at stage II; and 2 were at stage I. The mean duration of follow-up was 50.7 6 7.8 (range, 43-70) months. Seventeen patients were treated with modified radical mastectomy and chemotherapy, and 1 was treated with only modified radical mastectomy.
The mean total Hb concentrations of the metastasis and control groups were 275.3 6 63.0 (range, 165.0-405.1) and 210.6 6 58.6 (range, 116.9-310.6) lmol/L, respectively (Figures 1-3 (Figures 2-4) , indicating a significantly higher value in the metastasis group (P 5 .027).
To analyze the correlation between microvessel density and total Hb, we conducted a linear regression analysis of the two and generated a scatterplot ( Figure  5 ). The two were linearly correlated (r 5 0.584, P 5 <.001).
According to the results of the paired study, an ROC curve analysis was conducted to evaluate the diagnostic performance of DOT for predicting recurrence or metastasis in patients with breast cancer. In the group of 23 cases with recurrence or metastatic disease, the mean age was 52.4 6 10.2 (range, 34-70) years; the duration of follow-up was 22.6 6 16.3 (range, 4-64) months; and the mean total Hb concentration was 263.0 6 65.1 (range, 135.0-405.1) lmol/L. In the group of 161 cases without recurrence or metastatic disease, the mean age was 51.3 6 10.9 (range, 28-79) years; the duration of follow-up was 55.9 6 9.5 (range, 43-70) months; and the average total Hb concentration was 215.0 6 82.0 (range, 28.5-420.0) lmol/L). The ROC curve analysis showed that the area under the curve of DOT was 0.660, and that at a total Hb cutoff value of 221.7 lmol/ L, the sensitivity and specificity for predicting recurrence or metastasis were 0.826 and 0.516, respectively ( Figure 6 ).
Discussion
Over the last 20 years, optical imaging using nearinfrared light has become one of the main focuses of biomedical optics research, especially in breast imaging. 1 It can be combined with several imaging techniques, such as radiography, US imaging, MRI, and positron emission tomography. [3] [4] [5] [11] [12] [13] [14] [15] [16] [17] Now, it is used in the diagnosis of benign and malignant breast diseases and monitoring patient responses to neoadjuvant chemotherapy. 18 As a combined technique, US-guided DOT is inexpensive, convenient, and easy to perform, and it has broad application prospects in clinical practice. Ultrasound-guided DOT acquires structural information by using a US transducer and uses near-infrared light to detect the levels of oxyhemoglobin and deoxyhemoglobin in tissues, which exist in the vessels. In theory, the total Hb concentration indirectly reflects the blood supply in breast cancer to a certain extent. Zhu et al 19 performed a study of breast cancer in which US-guided DOT images were compared with the microvessel densities of tissue sections and found that the total Hb and microvessel density had a linear correlation. Our results are consistent with their findings. Lesions with a higher total Hb concentration have relatively higher microvessel density. Microvessel density is the reference standard for quantitative evaluation of the intratumoral blood supply. Our results indicate that the total Hb concentration can represent the tumor's blood supply. This idea is the theoretical basis for applying DOT to detect benign and malignant breast diseases and to evaluate chemotherapeutic effects. Microvessel density can only be obtained by pathologic diagnosis after surgery, whereas DOT is a noninvasive imaging modality without ionizing radiation, and repeated measurements can easily be made before surgery. 20 It can provide quantitative information on the tumor blood supply and help physicians assess the patient's condition. Therefore, DOT is very valuable and promising.
Many studies have reported that the blood supply plays an important role in the development of tumors. Microvessel density is associated with the invasion and metastatic potential of breast cancer. 7, 21 Because microvessels provide the necessary oxygen and nutrients for tumor growth and promote tumor cell metastasis, increases in the number of microvessels and the microvessel surface area may increase the probability of tumor cell metastasis. 7, 22 Microvessel density is closely related to the overall and disease-free survival rates in breast cancer. 8 In our study, the total Hb concentration and microvessel density in patients with recurrence or metastatic disease within 3 years after surgery were higher than in those without recurrence or metastatic disease within 3 years after surgery. This finding shows that the blood supplies of these lesions were more abundant. To survive and proliferate in a new location, tumor cells must stimulate the development of new blood vessels, and those surviving cells are more likely to be derived from primary tumors with higher angiogenic activity. 10 Several studies have found that the total Hb concentration was significantly correlated with the tumor estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 status, 6 ,23 all of which are prognostic factors. Ki-67 is considered a biomarker of cancer proliferation, and human epidermal growth factor receptor 2 is related to cell proliferation, differentiation, and survival. 23 That is, the total Hb concentration can reflect the functional status, angiogenic activity, and malignant degree of tumor cells. Lesions with a higher total Hb concentration have increased potential for malignancy and are more likely to metastasize. These aspects were why the total Hb concentration was associated with tumor development and metastasis.
Based on the above analysis, DOT is a promising technique for predicting the prognosis of breast cancer. An ROC curve analysis was conducted to evaluate the efficacy of DOT as a diagnostic test. At a total Hb threshold of 221.7 lmol/L, the sensitivity and specificity of DOT for predicting recurrence or metastasis and the area under the curve were 0.826, 0.516, and 0.660, respectively. Diffuse optical tomography had poor diagnostic performance, although there was a significant difference in the prognosis. This result may be because recurrence or metastasis of breast cancer is a complex biological process and is influenced by many factors. In addition to microvessels, genes and molecular biology play important roles in the development of recurrence and metastasis of breast cancer. Tumors with the same total Hb concentration may have different metastatic activity of individual breast cancer cells. Additionally, the blood supply only reflects the immediate state of a tumor because of the combined effects of tumor angiogenic factors and antiangiogenic factors 24 ; thus, perhaps only a varied balance of the blood supply can truly reflect the angiogenic activity of tumors. This factor may be the reason for the poor diagnostic efficacy of DOT. Additionally, the limited follow-up duration and number of patients with recurrence or metastasis included in this study may have influenced our results. However, the sensitivity of DOT was relatively higher than the specificity; thus, an early warning can be given to those patients with a total Hb concentration higher than 221.7 lmol/L. A higher total Hb concentration may suggest that the patient may have a relatively poorer prognosis and may require closer follow-up.
Compared with DOT, mammography, US, and MRI assess the prognosis of breast cancer mainly by using conventional prognostic factors, such as tumor size, shape, margins, and internal echoes. Research has shown that the American College of Radiology Breast Imaging Reporting and Data Systems used for mammography and US had important prognostic factors, and the prognosis of Breast Imaging Reporting and Data System category 5 was poorer than that of categories 3 and 4. 25, 26 Few researchers have reported the sensitivity and specificity of the above prognostic factors in evaluating the prognosis of breast cancer using mammography and US. Another study showed that tumor size on MRI was positively correlated with the risk of recurrence, and the enhancement texture on MRI was negatively correlated with the risk of recurrence. The ability of MRI to predicting the prognoses of different phenotypes of breast cancer ranged from 0.55 to 0.88. 27 Our research did not consider the phenotypes of breast cancer and, thus, cannot be compared with the above study. Ultrasound and MRI can also assess the prognosis of breast cancer in terms of the blood supply on color Doppler flow imaging, contrast-enhanced US, or an enhanced MRI mode, but they cannot quantify a tumor's blood supply. Diffuse optical tomography is a new functional modality that can evaluate the tumor blood supply quantitatively. It provides more functional information for physicians. In addition to the blood supply, DOT can evaluate the angiogenic activity and metabolism of tumor cells.
Currently, DOT is mostly used in the diagnosis and differential diagnosis of breast diseases before surgery, 3, 4 but the diagnostic performance for breast lesions was not significantly improved when using US-guided DOT compared with US alone. 28 Some research has focused on the correlation between total Hb and angiogenesis factor. 29 However, none have considered the possible correlation between DOT and the breast cancer prognosis. Our group reported that a high total Hb concentration was associated with preoperative axillary lymph node metastasis in breast cancer, 30 but for the first time to our knowledge, we explored the relationship between DOT and postoperative metastasis. Our results suggest that total Hb can be used as an indicator of breast cancer prognosis. This finding provides a reference for studying the stratification and mechanism of metastasis in breast cancer and can help physicians identify patients with a high risk of metastasis and make clinical decisions.
Our study still had some limitations. During the initial stage, we attempted to use the estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, p53, and Ki-67 as matching factors, but we did not find enough patients to serve as a control group. This study only considered several prognostic factors. Although DOT is easy to perform, and consistency between the observers in total Hb measurements is high, 28 there are still some factors that can influence DOT measurements, such as the size, location, and depth of lesions, partial volume effects, relative movement between the transduce and breast, and heterogeneous tissue. 23, 31 These may have been the causes of the outlier measurements present in the control group seen in our box plot. However, the correlation coefficient between microvessel density and total Hb was low, which may have been due to the small number of cases. More cases should be enrolled in a future study to further evaluate the relationship between the two. Currently, microvessel density is a widely used index to evaluate the tumor blood supply, but the correlation between microvessel density and the prognosis is still controversial. 21, 22, 24 Our results are consistent with past reports. 21, 22 The selection of regions with the highest microvessel density, heterogeneity of vascular distribution, and variability within observers may be the causes of the different results. In our study, the duration of follow-up was limited to within 3 years after surgery. The prognosis at 5 years or longer after surgery remains unknown. The correlation between total Hb and the timing or site of metastasis remains unclear. In the future, we will conduct a longer follow-up and consider more prognostic factors to further study the relationship among DOT, microvessel density, and the prognosis.
In conclusion, DOT is a noninvasive imaging modality without ionizing radiation, and it can evaluate the blood supply of breast tumors before surgery. The total Hb concentration was significantly different between groups on a prognostic level, with patients with a higher total Hb concentration having a higher risk for a poor prognosis. Diffuse optical tomography provides a new method for evaluating the prognosis of breast cancer. Further studies will help physicians understand and use this technology better in the future.
